Nonopioid Pain Management

Most patients with reduced opioid prescriptions during cannabis use had chronic musculoskeletal pain.

Catch up on important nonopioid pain management news from November 2024.

A number of new, nonopioid osteoarthritis treatment options are either available for patients or in the development pipeline.

NSAIDS are typically the first line of treatment for axial spondyloarthritis.

Chronic pain is more prevalent—and more severe—in veterans compared with the general US population.

Researchers explored the benefits of tai chi and prevalence of liver disease in patients with osteoarthritis.

Investigators evaluated the role that cannabis plays in pain management in different populations with rheumatic diseases.

The Mediterranean diet is largely considered one of the healthiest diets.

Researchers aimed to determine the frequency of pain assessments and the extent of pain scores by age for patients undergoing traumatic surgery.

Researchers evaluated the efficacy of a self-managed intervention vs enhanced usual care.

Melissa Durham, PharmD, MACM, reveals how pharmacists are uniquely positioned to counsel patients on nonopioid pain management.

In a recent clinical trial, weekly semaglutide demonstrated promise as a nonsurgical, nonopioid intervention for reducing knee osteoarthritis pain.

Researchers conducted a systematic review of randomized trials to determine the efficacy of ketamine for patients with cancer.

Research presented at AMCP Nexus 2024 underscored and explored the need for treatments that can prevent or mitigate flare-ups in patients with AD.

New research presented at AMCP Nexus 2024 highlighted the effectiveness and cost-effectiveness of various migraine treatments, including onabotulinumtoxinA and fremanezumab, as well as the importance of migraine education programs for improving patient outcomes.

Multimodal analgesia provides more effective pain management—and leads to a decrease in opioid use.

Suzetrigine could represent the first new nonopioid drug in a distinct class of pain medications in approximately 20 years.

Acupuncture, a practice with thousands of years of history, has become increasingly accepted in mainstream medicine.

Research is limited on the effectiveness and efficacy of this class of medications.

Patients with chronic migraine can frequently overuse acute medications, leading to medication overuse headaches.

Whether patients present with complaints of an aching muscle from a workout or a sudden twinge in the back, consider recommending these topical analgesics.

Although there has recently been an effort to improve pediatric pain treatment, it is still often underestimated and not adequately managed.

Researchers aimed to determine whether or not opioids were appropriate for treating adolescents experiencing chronic pain.

Researchers conducted a meta-analysis and systematic review to determine the efficacy of using antidepressants to treat older adults for knee osteoarthritis pain.

“By encouraging active self-management using health coaching principles, the WalkBack intervention might be able to reduce the prevalence of recurrent low back pain and associated burden on health care systems,” wrote investigators.

Mark Garofoli combined personal anecdotes with professional expertise to deliver a compelling presentation on kidney stone pain at this year’s PAINWeek National Conference.

“Reducing abdominal adiposity may be considered a target for chronic pain management, particularly in those with pain in multiple sites and widespread pain,” wrote investigators.

Click Therapeutics announced that CT-132 met its primary endpoint in the phase 3 ReMMi-D trial.

The investigational oral, selective NaV1.8 pain signal inhibitor from Vertex Pharmaceuticals demonstrated a favorable benefit/risk profile in 3 phase 3 trials.

With growing concerns around opioid use disorder, interventional pain management for patients with cancer can provide effective relief without the side effects associated with medication.